LPTC Leap Technology Inc (CE)

Le@P Technology, Inc. (OTCBB:LPTC), a company focused on acquiring and commercializing synergistic technologies to develop advanced products, today announced the hiring of Howard Benjamin, Ph.D., as Vice President of Research and Development. Dr. Benjamin has worked in the pharmaceutical industry with a focus on drug discovery and development for more than fifteen years. He joins Le@P from DAIAMED, LLC, where he created and led their biology and preclinical programs. Prior to DAIAMED, he was founding scientist of Pharmaceutical Peptides and Vice President for Discovery Research of Praecis Pharmaceuticals. �Le@P is delighted to welcome Howard who brings to the Company a wealth of experience in discovery research and corporate level supervision,� said Donald Ciappenelli, Ph.D., CEO of Le@P Technology. �Howard�s background and leadership experience clearly strengthens our team and will allow us to move aggressively and advance programs important to the Company.� Dr. Ciappenelli continued, �Howard�s joining us at this critical stage is most welcome timing. With his technical and scientific expertise, as well as his skills in internal and external corporate management and partnerships, he clearly has an ideal background to contribute to our future success.� Commenting on his new position, Dr. Benjamin said, �I am very pleased to be on board such an exciting venture that offers so many possibilities for product development. I look forward to bringing my experience in the field and leadership capabilities to the opportunity to help take Le@P through its next stages of growth and development, by seeking to bring exciting new products to market and forge corporate partnerships.� Statements about Le@P�s future expectations, including without limitation, future revenues and earnings, plans and objectives for future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are �forward-looking statements� within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. Le@P intends that such forward-looking statements be subject to the safe harbor created thereby. Since these statements involve risks and uncertainties, including but not limited to economic, competitive, governmental, regulatory, contractual and technological factors affecting Le@P�s operations, markets and profitability, Le@P�s actual performance could differ materially and adversely from its projected results.